Skip to main content
logo
Vedanta Limited (NSE:VEDL)
India flag India · Delayed Price · Currency is INR
424.45
-1.20 (-0.28%)
Aug 1, 2025, 3:30 PM IST

Intra-Cellular Therapies Revenue

In the fiscal year ending June 30, 2025, Vedanta had annual revenue of 1.54T INR with 1.45% growth. Vedanta had revenue of 374.34B in the quarter ending June 30, 2025, with 6.23% growth.

Revenue
1,535.31B
Revenue Growth
+6.57%
P/S Ratio
1.08
Revenue / Employee
88.58M
Employees
17,332
Market Cap
1,662.42B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20251,535.31B21.95B1.45%
Mar 31, 20251,513.36B103.80B7.36%
Jun 30, 20241,409.56B-12.16B-0.86%
Mar 31, 20241,421.72B-37.15B-2.55%
Mar 31, 20231,458.87B142.07B10.79%
Mar 31, 2022 Pro Pro Pro
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UltraTech Cement784.12B
Asian Paints338.41B
Grasim Industries1,484.78B
Pidilite Industries131.40B
Solar Industries India75.40B
Shree Cement192.83B
Jindal Steel497.65B
Coromandel International263.99B
Revenue Rankings

Vedanta News

More News